Orlando-based specialty pharmaceutical company, Profounda announced it has received the US Food and Drug Administration’s Orphan Drug Designation for the use of Impavido (miltefosine) to treat Granulomatous...

On Sunday’s show, I had two fantastic guests to discuss two very interesting topics. In the first half, the Dean of the National School of Tropical Medicine at Baylor College of Medicine in Houston...

Last week, we learned of a miracle of sorts. Florida Hospital for Children in Orlando announced that 16-year-old Sebastian Deleon had survived an infection with the amoebic parasite, Naegleria fowleri,...

In a follow-up on the case of Naegleria fowleri infection in South Carolina recently reported, the identification of the patient is now known– 11-year-old Hannah Katherine Collins, according to...